AMP Capital Investors’s NuVasive, Inc. NUVA Stock Holding History

AMP Capital Investors’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-5,533	Closed	-$288K	–	1210
2018 Q2	$288K	Buy	+5,533	New	+$290K	﹤0.01%	1080
2017 Q3	–	Sell	-5,200	Closed	-$402K	–	1185
2017 Q2	$402K	Buy	+5,200	New	+$389K	﹤0.01%	1009

Other funds holding NUVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

AMP Capital Investors's NUVA Position: Q3 2018 in Review

AMP Capital Investors sold out of NuVasive, Inc. (NUVA) in Q3 2018, closing a stake of 5,533 shares — an estimated $288K sold.

AMP Capital Investors first reported a position in NUVA in Q2 2017 and held it in 2 quarters. The position peaked at $402K in Q2 2017. 287 funds tracked by Wall St. Rank hold NUVA as of Q3 2018.

AMP Capital Investors reported no remaining NuVasive, Inc. position as of Q3 2018 after selling out during the quarter.
AMP Capital Investors sold 5,533 NuVasive, Inc. shares in Q3 2018, an estimated $288K.
AMP Capital Investors first reported a position in NuVasive, Inc. in Q2 2017 and held it in 2 quarters.
AMP Capital Investors's NuVasive, Inc. position peaked at $402K in Q2 2017.
287 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2018.

Based on AMP Capital Investors's 13F filing for Q3 2018, filed 13 Nov 2018.